| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Exit Filing | 10% Owner +1 more
4 companies
Tang Kevin is a Director at AUPH with holdings across 4 companies. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $179.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 19, 2017 | HRTX Heron Therapeutics, Inc. /de/ | Director, 10% Owner | Buy | 2,459,016 | $12.20 | $29,999,995.20 | +41.9% | |
| Jun 10, 2015 | HRTX Heron Therapeutics, Inc. /de/ | Director, 10% Owner | Buy | 121,212 | $24.75 | $2,999,997.00 | +2.6% | |
| Jun 2, 2015 | HRTX Heron Therapeutics, Inc. /de/ | Director, 10% Owner | Buy | 150,000 | $20.62 | $3,092,285.12 | +1.1% |